M2Cloud Signs MoU with Thales to Enter Global IoT-Based Biopharmaceutical Cold Chain Market


February 25, 2022 – M2Cloud, the Korean leader in biological cold chain technology, announced that it has developed an IoT-based “LTE monitoring system” optimized for biopharmaceutical monitoring with Thales, a world leader in IoT communication modules.

© M2Cloud

M2Cloud has also signed a Memorandum of Understanding (MOU) with Thales Korea to enter the global IoT-based biological cold chain market with technical agreements to work on the development of new biological cold chain systems. generation.

In the future, the two companies will strengthen their cooperation for the development of optimized products for biological cold chains and global expansion, such as technology cooperation to develop biomedicine monitoring IoT devices and to ensure stable supply. of IoT modules by combining state-of-the-art security. and IoT technology,

Unlike Bluetooth devices for near-field communication, the new IoT cold chain system which is equipped with low-power LTE communication chip, does not require the adoption of an additional gateway or complex configurations such as internet connectivity. It can remotely check real-time temperature and location information by simply turning on the power, which makes it suitable for real-time monitoring of refrigerators, refrigerated warehouses, etc., as well as box tracking. delivery transported in real time.

In particular, because it provides real-time visibility and data integrity, and can check temperature history without data loss in the event of a power outage or network failure, it improves the safety of pharmaceutical products with technologies optimized for biopharmaceutical management, such as vaccines that confirm the validity of products with a temperature history.

In addition, it can provide services in accordance with global biopharmaceutical regulations as well as the conditions of defense against manipulation of temperature data stipulated in the revision of「Management rules for the manufacture and sales of biological products, etc.」promulgated. by the Ministry of Food and Pharmaceutical Safety.

M2cloud ranks No. 1 in Korea for IoT security authentication technology that meets all IoT security standards, including data stability, encryption, software integrity and security. M2cloud established an integrated logistics system for COVID-19 in 2021 with real-time visibility across the entire supply chain, ensuring integrity, proof of compliance to ensure product quality, optimized IoT technology for temperature sensitivity and cloud technology for ESG practices.

M2cloud also established and operated a cold chain system throughout the process of receiving, storing and delivering COVID-19 vaccines from AstraZeneca (refrigeration), Janssen (freezing) and Pfizer (ultra-low temperature), all of which are biological agents.

In 2022, we plan to develop and supply competitive products in cooperation with various foreign partner companies to enter the global market while stably supplying new products to the domestic bio/medicine cold chain market.

MOON Jin-soo, CEO of M2cloud

For a quarter of a century, customers across all industries have trusted Thales’ cutting-edge IoT solutions to seamlessly connect and secure IoT devices and help them transform real-time data into effective decision-making. We are proud to work with M2cloud to help keep their cold chain monitoring and management solutions connected, and to bring solutions that support the healthcare industry in Korea.

Sandy GILLIO, Country Director and Managing Director of Thales in Korea


Comments are closed.